|
|
||||||||
Ann Thorac Surg 2003;76:1896-1900
© 2003 The Society of Thoracic Surgeons
a Department of Surgery and Pediatrics, Tulane University Medical Center, New Orleans, Louisiana, USA
Accepted for publication June 19, 2003.
* Address reprint requests to Dr Deleon, Tulane University Medical Center, 1430 Tulane Ave SL-22, New Orleans, LA 70112, USA
BACKGROUND: Various pulmonary valve substitutes, with their inherent limitations, have been used in children and young adults. We chose the Medtronic Freestyle (Medtronics, Minneapolis, MN) valve because of its excellent hemodynamics, known durability in adults, and design features that allow modifications during implantation.
METHODS: Over a 3 1/2 year period the Freestyle valve was implanted in 47 patients age 2 to 58 years (mean 14.2, median 12.0) in the pulmonary position. All patients had pulmonic stenosis and(or) insufficiency from previous operations for tetralogy (27), pulmonary atresia (6), truncus (4), or other diagnosis (10). The indication for surgery was pure pulmonary insufficiency in 11 patients, pulmonic stenosis in 3, and mixed stenosis and insufficiency in 33. Root replacement technique was used with additional enlargement of the pulmonary artery branches in 10 patients.
RESULTS: Intraoperatively, one patient sustained a right ventricle tear and one a circumflex coronary artery injury during the dissection. There was one postoperative death. Two patients developed late subvalvular pannus formation, one of whom required reoperation. One patient was found to have an echo gradient of 95 mm Hg due to decreased leaflet motion and underwent cardiac catheterization at which the peak systolic gradient was determined to be 50 mm Hg. He has not required reintervention during his 3 1/2 years of follow-up. The remaining 43 patients have minimal gradients or insufficiency. All surviving patients are in New York Heart Association (NYHA) Class I.
CONCLUSIONS: The Medtronic Freestyle valve is an attractive alternative for RVOT (right ventricular outflow tract) reconstruction in children. It is readily available, versatile, and has excellent hemodynamic characteristics. Although long term follow-up is not yet available, longevity of this prosthesis, and freedom from complications, will hopefully be superior to valves with stents.
This article has been cited by other articles:
![]() |
B. Chiappini, C. Barrea, and J. Rubay Right Ventricular Outflow Tract Reconstruction With Contegra Monocuspid Transannular Patch in Tetralogy of Fallot Ann. Thorac. Surg., January 1, 2007; 83(1): 185 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Brown, M. Ruzmetov, M. D. Rodefeld, P. Vijay, and M. W. Turrentine Right Ventricular Outflow Tract Reconstruction With an Allograft Conduit in Non-Ross Patients: Risk Factors for Allograft Dysfunction and Failure Ann. Thorac. Surg., August 1, 2005; 80(2): 655 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Erek, Y. K. Yalcinbas, and T. Sarioglu Durability of Stentless Bioprostheses for Right Ventricular Outflow Tract Reconstruction Ann. Thorac. Surg., June 1, 2005; 79(6): 2202 - 2203. [Full Text] [PDF] |
||||
![]() |
S. Y. Deleon, J. G. Dorotan, and J. L. Myers Reply Ann. Thorac. Surg., June 1, 2005; 79(6): 2203 - 2203. [Full Text] [PDF] |
||||
![]() |
V. Gober, P. Berdat, M. Pavlovic, J.-P. Pfammatter, and T. P. Carrel Adverse Mid-Term Outcome Following RVOT Reconstruction Using the Contegra Valved Bovine Jugular Vein Ann. Thorac. Surg., February 1, 2005; 79(2): 625 - 631. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |